Skip to main content
. 2018 Jan 30;9(14):11559–11571. doi: 10.18632/oncotarget.24338

Figure 4. Percentage of patients developing grade I/II or III/IV toxicity according to the AUC range (black columns: below or within the therapeutic range, white columns: above the therapeutic range).

Figure 4